Mumbai. Thursday, 28 May 2026 Indian pharmaceutical major Zydus Lifesciences has announced a crucial tactical modification to its ongoing share buyback program. Acting on the recommendations of its authorized buyback committee, the company has officially approved a significant increase in the buyback price, offering to repurchase shares from eligible investors …
Read More »
Matribhumi Samachar English